Skip to main content
Clinical Trials/NL-OMON44599
NL-OMON44599
Completed
Phase 3

Minimally invasive surgery for Ponto bone anchored hearing implants - C50

Oticon Medical AB0 sites62 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
deafness
Sponsor
Oticon Medical AB
Enrollment
62
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patient, i.e. \>\= 18 years of age
  • Eligible for the Ponto system
  • Signed informed consent

Exclusion Criteria

  • A potential subject who meets the inclusion criteria for Ponto surgery, is willing to participate in the trial and meets any of the following criteria will be excluded from participation in this study.
  • \- Known history of immunosuppressive disease
  • \- Use of systemic immunosuppressive medication
  • \- Receiving bilateral bone anchored hearing system
  • \- Relevant dermatological diseases as judged by the investigator
  • \- Not being able to finish the study, for example because of failure to complete the questionnaires
  • \- Participating in another study with medical aids or medication
  • \- When there is no suitable implantation\-site for the 4 mm implant during surgery because of insufficient bone quality.

Outcomes

Primary Outcomes

Not specified

Similar Trials